Home / Inspections / 1223087

FDA Inspection 1223087 — STERIS Corporation

STERIS Corporation — FEI 1937531

The FDA completed an inspection of STERIS Corporation on November 6, 2023 in Saint Louis, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 6, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Saint Louis, MO (United States)

Facility

Other inspections at this facility

  • 977303 (NAI Wed Jun 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 915094 (NAI Fri Feb 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 724872 (NAI Tue May 17 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 599535 (VAI Thu Jul 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources